Portal de Periódicos da CAPES

De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia

2020; Nature Portfolio; Volume: 23; Issue: 2 Linguagem: Inglês

10.1038/s41593-019-0565-2

1546-1726

Elliott Rees, Jun Han, Joanne Morgan, Noa Carrera, Valentina Escott‐Price, Andrew Pocklington, Madeleine Duffield, Lynsey S. Hall, Sophie E. Legge, Antonio F. Pardiñas, Alexander Richards, Julian Roth, Tatyana Lezheiko, Nikolay Kondratyev, Василий Глебович Каледа, В. Е. Голимбет, Mara Parellada, Javier González‐Peñas, Celso Arango, Micha Gawlik, George Kirov, James Walters, Peter Holmans, Michael O’Donovan, Michael J. Owen,

Genomics and Rare Diseases

Schizophrenia is a highly polygenic disorder with important contributions from both common and rare risk alleles. We analyzed exome sequencing data for de novo variants (DNVs) in a new sample of 613 schizophrenia trios and combined this with published data to give a total of 3,444 trios. In this new data, loss-of-function (LoF) DNVs were significantly enriched among 3,471 LoF-intolerant genes, which supports previous findings. In the full dataset, genes associated with neurodevelopmental disorders (n = 159) were significantly enriched for LoF DNVs. Within these neurodevelopmental disorder genes, SLC6A1, which encodes a γ-aminobutyric acid transporter, was associated with missense-damaging DNVs. In 1,122 trios for which genome-wide common variant data were available, schizophrenia and bipolar disorder polygenic risk were significantly overtransmitted to probands. Probands carrying LoF or deletion DNVs in LoF-intolerant or neurodevelopmental disorder genes had significantly less overtransmission of schizophrenia polygenic risk than did non-carriers, which provides a second robust line of evidence that these DNVs increase liability to schizophrenia. Rees et al. show that de novo mutations in the gene SLC6A1, and more broadly across evolutionary constrained genes and genes implicated in neurodevelopmental disorders, increase the risk for developing schizophrenia.